Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
December 29, 2025
Medicare and Medicaid Demos Seek to Impose MFN Pricing: An Overview of GENEROUS, GLOBE, and GUARD
December 22, 2025
EUROPE - Major Regulatory Developments in Pharmaceuticals, Biotechnology, and Medical Devices
February 9, 2026
CVN Ranks King & Spalding’s Terumo Trial Victory as the #1 Most Impressive Defense Verdict of 2025
January 30, 2026
K&S represents Boehringer Ingelheim in its successful effort to have more than 200 Zantac suits tossed out by a Delaware state trial judge
January 6, 2026
Former Federal Prosecutor Rebeca Ojeda Rejoins King & Spalding’s Product Liability and Mass Torts Practice as Partner
July 8, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Trial